ReviewWorld journal of hepatology2019

Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease.

Amr Dokmak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.